Drug Trial Radar · NCT00345501
Iloprost for Prevention of Contrast-Mediated Nephropathy in High-Risk Patients Undergoing Coronary Angiography and/or Intervention
Last checked: Nov 20, 2026Latest source record: Aug 24, 2007 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
208
Actual
Start
Nov 2005
Primary completion
Not stated
Study completion Jul 2007
Sponsor
- Lead sponsor
- Onassis Cardiac Surgery CentreAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jun 28, 2006
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- Who can join
- All sexes, from 18 years, up to 90 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The prevention of contrast-mediated nephropathy (CMN), which accounts for considerable morbidity and mortality, remains a vexing problem. Contrast induced renal vasoconstriction is believed to play a pivotal role in the CMN mechanism. The aim of this study is to examine the efficacy of the prostacyclin analogue iloprost (dose 1ng/kg/min) in preventing CMN in high-risk patients undergoing a coronary procedure.
Conditions
- Renal Insufficiency, Chronic
- Coronary Angiography
- Angioplasty, Transluminal, Percutaneous Coronary
Interventions
IloprostDrug
Iloprost 1ng/kg/min IV starting 1 hour before the procedure and continuing for 4 hours after its end
PlaceboDrug
Placebo IV (Normal saline) starting 1 hour before the procedure and continuing for 4 hours after its end
Primary outcomes
What the sponsor says the trial is designed to measure.
- CMN is defined as an absolute increase of serum creatinine concentration of at least 0.5 mg/dlTime frame: 2-5 days after the procedure
- or CMN is defined as a relative rise of at least 25% from baseline on the follow-upTime frame: blood sample drawn at 2-5 days after the procedure
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Onassis Cardiac Surgery Centre
Athens, Greece
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.